首页> 外文会议>Computing in Cardiology Conference >Automaticity in Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells as Result of Different Mechanisms
【24h】

Automaticity in Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells as Result of Different Mechanisms

机译:不同机制导致的人类诱导多能干细胞衍生的心肌细胞的自动化

获取原文

摘要

Cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs) are nowadays one of the most studied cell types, especially for their role as in vitro models to test drug safety. Here we propose an update of our recent Paci2018 hiPSC-CM model, focusing particularly on the mechanisms underlying the action potential (AP) automaticity, i.e. one of the clearest markers of hiPSC-CM immaturity. We used two recently published formulations of the fast Na+ (INa) and the funny (If) currents to improve our previous fitting of in vitro experiments. We then used an optimization framework to automatically identify the parameters formalizing currents/mechanisms for which in vitro data were not available. We identified a model producing APs and Ca2+ transients (CaTrs) in agreement with literature and our in-house CaTr data. We showed that a strong (90%) Na+/Ca2+ exchanger (INCX) block suppresses the spontaneous APs, in agreement with in vitro data. The new Paci2019 was further validated against the in vitro experiments used for the Paci2018 model, showing that this update did not affect the capability of the new model to simulate mechanisms (e.g. responses to drugs or proarrhythmic events) successfully reproduced by the previous model. In conclusion, the Paci2019 model represents an improved tools for in silico studies e.g. on hiPSC-CM responses to drugs.
机译:如今,衍生自人诱导多能干细胞(hiPSC-CMs)的心肌细胞是研究最多的细胞类型之一,尤其是其作为体外模型来测试药物安全性。在这里,我们提议对我们最近的Paci2018 hiPSC-CM模型进行更新,特别关注潜在动作(AP)自动化的潜在机制,即hiPSC-CM不成熟性最清晰的标志之一。我们使用了两种最近发表的快速钠的配方 + (一世 Na )和有趣的(我 f ),以改善我们以前进行的体外实验。然后,我们使用了一个优化框架来自动识别参数,这些参数使目前尚无体外数据的电流/机制形式化。我们确定了产生AP和Ca的模型 2 + 瞬态(CaTrs)与文献和我们内部的CaTr数据一致。我们显示出强(90%)的钠 + /钙 2 + 交换器(I NCX )抑制与体外数据一致的自发性AP。新的Paci2019已针对Paci2018模型所用的体外实验进行了进一步验证,表明此更新不影响新模型模拟由先前模型成功复制的机制(例如对药物的反应或心律失常事件的反应)的能力。总之,Paci2019模型代表了计算机研究的改进工具,例如关于hiPSC-CM对药物的反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号